FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048884017> ?p ?o ?g. }

• W3048884017 endingPage "B119" @default.
• W3048884017 startingPage "B119" @default.
• W3048884017 abstract "Abstract Despite cancer being the leading cause of death across most racial/ethnic groups, Hispanic women have the second highest mortality rate attributed to diabetes (4.7%) according to the Centers for Disease Control and Prevention (CDC). While cancer and diabetes are two distinct diseases, previous studies have demonstrated that diabetic women have a poor chance of breast cancer survival when compared to nondiabetic women. Well-known key drivers of hyperinsulinemia and insulin resistance, such as insulin and AMPK, are also those involved in breast cancer. This link could possibly contribute to the increased mitogenic effects and risk for aggressive breast cancers in Hispanic women. Based on these findings, metformin, a drug standardly used to treat and prevent hyperglycemia, may be a possible alternative (other than tamoxifen) for breast cancer prevention. Eat, Move, Live (EML), a 5-week community-based program, focuses on targeting possible treatments of chronic diseases and risk reduction through attitude and lifestyle modifications. Exercise, nutritional and health awareness classes were implemented to change participants' perspectives regarding chronic diseases and their susceptibility to other morbidities. Questionnaires were given to the participants at baseline and at two follow-ups (5 weeks and 12 weeks) to assess any changes in their attitudes, behaviors, nutrition, lifestyle and beliefs around taking medication for preventative treatments. A total of 56 participants' pretreatment responses were collected via a five-point Likert scale (1-strongly disagree, 5-strongly agree). Demographic data showed that 69% of the respondents were Hispanic women, of whom 46% completed an education level of high school or less. A majority of the responses averaged a “neutral” response to taking medication for management and prevention of diabetes. We infer that their inability to select a stance in their responses may be associated with the lack of knowledge that the community has regarding chronic diseases and risk-prevention methods. Therefore, we anticipate that availability of proper education tools and resources is essential to potentially prevent future morbidities and mortalities. Ultimately, we aim to establish a pilot study that emphasizes the necessity and importance of interventional programs, like EML, to enhance chemoprevention using metformin and improve health outcomes in high-risk breast cancer populations. Citation Format: Mayra Serrano, Angelica Sanchez, Christine Thai, Katty Nerio, Cristal Resto, Marisela Garcia, Tanya A. Chavez, Laura L. Kruper, Veronica C. Jones, Lisa D. Yee, Alan Nuñez, Ellen J. Rippberger, Angela K. Wong, Noé R. Chávez, Karen Herold, Chidimma M.K. Kalu, Jackelyn A. Alva-Ornelas, Jerneja Tomsic, Krista M. Round, Regina Agulto, Margarita Robles, Ombeni M. Idassi, Kendall J. Kennedy, Christopher Sistrunk, Victoria L. Seewaldt. Receptiveness of metformin as a breast cancer prevention drug within the Hispanic community [abstract]. In: Proceedings of the Eleventh AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2018 Nov 2-5; New Orleans, LA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2020;29(6 Suppl):Abstract nr B119." @default.
• W3048884017 created "2020-08-18" @default.
• W3048884017 creator A5000359290 @default.
• W3048884017 creator A5004569740 @default.
• W3048884017 creator A5004692564 @default.
• W3048884017 creator A5013796890 @default.
• W3048884017 creator A5019052988 @default.
• W3048884017 creator A5023102311 @default.
• W3048884017 creator A5027175498 @default.
• W3048884017 creator A5030823966 @default.
• W3048884017 creator A5031678728 @default.
• W3048884017 creator A5036892399 @default.
• W3048884017 creator A5050277732 @default.
• W3048884017 creator A5053666840 @default.
• W3048884017 creator A5057277209 @default.
• W3048884017 creator A5058251797 @default.
• W3048884017 creator A5068013079 @default.
• W3048884017 creator A5071074432 @default.
• W3048884017 creator A5076645176 @default.
• W3048884017 creator A5076846225 @default.
• W3048884017 creator A5078638696 @default.
• W3048884017 creator A5079121091 @default.
• W3048884017 creator A5080229565 @default.
• W3048884017 creator A5085450275 @default.
• W3048884017 creator A5088404727 @default.
• W3048884017 creator A5088797066 @default.
• W3048884017 creator A5065548714 @default.
• W3048884017 date "2020-06-01" @default.
• W3048884017 modified "2023-10-02" @default.
• W3048884017 title "Abstract B119: Receptiveness of metformin as a breast cancer prevention drug within the Hispanic community" @default.
• W3048884017 doi "https://doi.org/10.1158/1538-7755.disp18-b119" @default.
• W3048884017 hasPublicationYear "2020" @default.
• W3048884017 type Work @default.
• W3048884017 sameAs 3048884017 @default.
• W3048884017 citedByCount "0" @default.
• W3048884017 crossrefType "journal-article" @default.
• W3048884017 hasAuthorship W3048884017A5000359290 @default.
• W3048884017 hasAuthorship W3048884017A5004569740 @default.
• W3048884017 hasAuthorship W3048884017A5004692564 @default.
• W3048884017 hasAuthorship W3048884017A5013796890 @default.
• W3048884017 hasAuthorship W3048884017A5019052988 @default.
• W3048884017 hasAuthorship W3048884017A5023102311 @default.
• W3048884017 hasAuthorship W3048884017A5027175498 @default.
• W3048884017 hasAuthorship W3048884017A5030823966 @default.
• W3048884017 hasAuthorship W3048884017A5031678728 @default.
• W3048884017 hasAuthorship W3048884017A5036892399 @default.
• W3048884017 hasAuthorship W3048884017A5050277732 @default.
• W3048884017 hasAuthorship W3048884017A5053666840 @default.
• W3048884017 hasAuthorship W3048884017A5057277209 @default.
• W3048884017 hasAuthorship W3048884017A5058251797 @default.
• W3048884017 hasAuthorship W3048884017A5065548714 @default.
• W3048884017 hasAuthorship W3048884017A5068013079 @default.
• W3048884017 hasAuthorship W3048884017A5071074432 @default.
• W3048884017 hasAuthorship W3048884017A5076645176 @default.
• W3048884017 hasAuthorship W3048884017A5076846225 @default.
• W3048884017 hasAuthorship W3048884017A5078638696 @default.
• W3048884017 hasAuthorship W3048884017A5079121091 @default.
• W3048884017 hasAuthorship W3048884017A5080229565 @default.
• W3048884017 hasAuthorship W3048884017A5085450275 @default.
• W3048884017 hasAuthorship W3048884017A5088404727 @default.
• W3048884017 hasAuthorship W3048884017A5088797066 @default.
• W3048884017 hasConcept C121608353 @default.
• W3048884017 hasConcept C126322002 @default.
• W3048884017 hasConcept C134018914 @default.
• W3048884017 hasConcept C143998085 @default.
• W3048884017 hasConcept C2777176818 @default.
• W3048884017 hasConcept C2777391703 @default.
• W3048884017 hasConcept C2779306644 @default.
• W3048884017 hasConcept C2780234812 @default.
• W3048884017 hasConcept C2780323712 @default.
• W3048884017 hasConcept C2780988686 @default.
• W3048884017 hasConcept C530470458 @default.
• W3048884017 hasConcept C555293320 @default.
• W3048884017 hasConcept C71924100 @default.
• W3048884017 hasConcept C74909509 @default.
• W3048884017 hasConceptScore W3048884017C121608353 @default.
• W3048884017 hasConceptScore W3048884017C126322002 @default.
• W3048884017 hasConceptScore W3048884017C134018914 @default.
• W3048884017 hasConceptScore W3048884017C143998085 @default.
• W3048884017 hasConceptScore W3048884017C2777176818 @default.
• W3048884017 hasConceptScore W3048884017C2777391703 @default.
• W3048884017 hasConceptScore W3048884017C2779306644 @default.
• W3048884017 hasConceptScore W3048884017C2780234812 @default.
• W3048884017 hasConceptScore W3048884017C2780323712 @default.
• W3048884017 hasConceptScore W3048884017C2780988686 @default.
• W3048884017 hasConceptScore W3048884017C530470458 @default.
• W3048884017 hasConceptScore W3048884017C555293320 @default.
• W3048884017 hasConceptScore W3048884017C71924100 @default.
• W3048884017 hasConceptScore W3048884017C74909509 @default.
• W3048884017 hasIssue "6_Supplement_1" @default.
• W3048884017 hasLocation W30488840171 @default.
• W3048884017 hasOpenAccess W3048884017 @default.
• W3048884017 hasPrimaryLocation W30488840171 @default.
• W3048884017 hasRelatedWork W2007405015 @default.
• W3048884017 hasRelatedWork W2033840628 @default.
• W3048884017 hasRelatedWork W2111784701 @default.
• W3048884017 hasRelatedWork W2154162573 @default.
• W3048884017 hasRelatedWork W2156708180 @default.

• next